1. ADRs following use of oral COVID-19 therapeutics (Paxlovid, Lagevrio) in New Zealand

   News item 17 December 2022 Pages: 1 - 1

2. COMIRNATY Original & Omicron BA.4/BA.5 for children: beware of errors

   News item 17 December 2022 Pages: 2 - 2

3. Corticosteroid-related pheochromocytoma crisis

   News item 17 December 2022 Pages: 3 - 3

4. Dupilumab- and tralokinumab-related eye disorders

   News item 17 December 2022 Pages: 4 - 4

5. EMA recommends market withdrawal of pholcodine in EU

   News item 17 December 2022 Pages: 5 - 5

6. Empagliflozin, dapagliflozin: risk of diabetic ketoacidosis and Fournier's gangrene

   News item 17 December 2022 Pages: 6 - 6

7. Microscopic colitis may be caused by various medicines

   News item 17 December 2022 Pages: 7 - 7

8. Newer antihyperglycaemics may increase risk of hypoglycaemia

   News item 17 December 2022 Pages: 8 - 8

9. OCALIVA now contraindicated in advanced primary biliary cholangitis

   News item 17 December 2022 Pages: 9 - 9

10. Montelukast-related ADRs in paediatric patients

    Clinical study 17 December 2022 Pages: 10 - 10

11. Obesity increases risk of irAEs in patients receiving nivolumab

    Clinical study 17 December 2022 Pages: 11 - 11

12. Polypharmacy increases risk of AEs in patients with AF initiating VKAs

    Clinical study 17 December 2022 Pages: 12 - 12

13. Other adverse reaction research

    News item 17 December 2022 Pages: 13 - 13

14. Abatacept

    Case report 17 December 2022 Pages: 14 - 14

15. Abatacept

    Case report 17 December 2022 Pages: 15 - 15

16. Abiraterone-acetate/prednisone

    Case report 17 December 2022 Pages: 16 - 16

17. Acetazolamide

    Case report 17 December 2022 Pages: 17 - 17

18. Acitretin/corticosteroids/prednisolone

    Case report 17 December 2022 Pages: 18 - 18

19. Ad26.COV2-S

    Case report 17 December 2022 Pages: 19 - 19

20. Ad26.cov2-s

    Case report 17 December 2022 Pages: 20 - 20

21. Adalimumab

    Case report 17 December 2022 Pages: 21 - 21

22. Adalimumab

    Case report 17 December 2022 Pages: 22 - 22

23. Adalimumab/ustekinumab

    Case report 17 December 2022 Pages: 23 - 23

24. Aflibercept/brolucizumab

    Case report 17 December 2022 Pages: 24 - 24

25. Alcohol

    Case report 17 December 2022 Pages: 25 - 25

26. Alectinib/crizotinib

    Case report 17 December 2022 Pages: 26 - 26

27. Alendronic-acid

    Case report 17 December 2022 Pages: 27 - 27

28. Allopurinol

    Case report 17 December 2022 Pages: 28 - 28

29. Alpelisib

    Case report 17 December 2022 Pages: 29 - 29

30. Alpelisib/enoxaparin-sodium/sirolimus

    Case report 17 December 2022 Pages: 30 - 30

31. Alprostadil/alprostadil alfadex/furosemide

    Case report 17 December 2022 Pages: 31 - 31

32. Amikacin

    Case report 17 December 2022 Pages: 32 - 32

33. Amiodarone/ascorbic acid

    Case report 17 December 2022 Pages: 33 - 33

34. Amiodarone/digoxin

    Case report 17 December 2022 Pages: 34 - 34

35. Amitriptyline

    Case report 17 December 2022 Pages: 35 - 35

36. Amlodipine/doxorubicin liposomal

    Case report 17 December 2022 Pages: 36 - 36

37. Amlodipine/tacrolimus

    Case report 17 December 2022 Pages: 37 - 37

38. Amoxicillin

    Case report 17 December 2022 Pages: 38 - 38

39. Amoxicillin/amoxicillin/clavulanic-acid

    Case report 17 December 2022 Pages: 39 - 39

40. Amoxicillin/clavulanic-acid/cotrimoxazole

    Case report 17 December 2022 Pages: 40 - 40

41. Amphotericin B

    Case report 17 December 2022 Pages: 41 - 41

42. Anidulafungin/caspofungin

    Case report 17 December 2022 Pages: 42 - 42

43. Anthracyclines/antineoplastics

    Case report 17 December 2022 Pages: 43 - 43

44. Antibacterial drugs

    Case report 17 December 2022 Pages: 44 - 44

45. Antibacterials

    Case report 17 December 2022 Pages: 45 - 45

46. Antidepressants/valproic-acid

    Case report 17 December 2022 Pages: 46 - 46

47. Antiepileptic drugs

    Case report 17 December 2022 Pages: 47 - 47

48. Antiepileptic drugs/immunosuppressants

    Case report 17 December 2022 Pages: 48 - 48

49. Antiepileptic-drugs

    Case report 17 December 2022 Pages: 49 - 49

50. Antiepileptics

    Case report 17 December 2022 Pages: 50 - 50